QuidelOrtho Corporation - Common Stock (QDEL)
11.96
-2.39 (-16.66%)
NASDAQ · Last Trade: Nov 5th, 12:58 PM EST
News & Press Releases
QuidelOrtho (QDEL) Q3 2026 Earnings Call Transcriptfool.com
China sales slump and a restructuring plan reshape the outlook
Via The Motley Fool · November 4, 2026
QDEL Q3 2026 deep dive: China pricing pressures and restructuring define outlook
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 11.6% year on year to $618....
Via StockStory · November 4, 2026
3 unpopular stocks we steer clear of
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Via StockStory · November 3, 2026
What QuidelOrtho (QDEL) Said on Its Q3 Earnings Callmarketbeat.com
QuidelOrtho (NASDAQ:QDEL) reported third-quarter revenue of $619 million, down 12% year over year on a constant-currency basis, as China pricing changes and softer respiratory testing demand continued to weigh on results. The company said revenue rose 3% excluding China, respiratory testing and the
Via MarketBeat · November 3, 2026
QuidelOrtho Corp (NASDAQ:QDEL) Q3 2026: EPS Beat, Revenue Miss, and Restructuring Planchartmill.com
Via Chartmill · November 3, 2026
QuidelOrtho (NASDAQ:QDEL) reports sales below analyst estimates in Q3 2026 earnings, stock drops 10.6%
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q3 2026, with revenue falling 11.6% year on year to $61...
Via StockStory · November 3, 2026
After-Hours Stock Movers: Nov. 3 Gainers and Loserschartmill.com
Via Chartmill · November 3, 2026
What to expect from QuidelOrtho’s (QDEL) Q3 earnings
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting results this Tuesday after market hours. Here’s what to expect. QuidelOrtho beat a...
Via StockStory · November 1, 2026
3 unprofitable stocks walking a fine line
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. A lack ...
Via StockStory · October 22, 2026
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after capital-intensive growth equities experienced sharp sell-offs as elevated bond yields r...
Via StockStory · October 16, 2026
QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q2 Earnings?
Over the past six months, QuidelOrtho’s shares (currently trading at $13.31) have posted a disappointing 17.3% loss, well below the S&P 500’s 12.8% gain. Thi...
Via StockStory · October 12, 2026
2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Via StockStory · September 25, 2026
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...
Via StockStory · September 23, 2026
3 Stocks Under $50 We Think Twice About
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via StockStory · September 1, 2026
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Via StockStory · August 26, 2026
3 Unprofitable Stocks with Warning Signs
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Via StockStory · August 21, 2026
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via StockStory · August 16, 2026
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcriptfool.com
China headwinds and respiratory uncertainty weigh on full-year guidance.
Via The Motley Fool · August 13, 2026
The 5 Most Interesting Analyst Questions From QuidelOrtho’s Q2 Earnings Call
QuidelOrtho’s second quarter results were met with a negative market reaction, reflecting investor concern over significant challenges in key markets. While ...
Via StockStory · August 13, 2026
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 Facing Challenges
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · August 10, 2026
Why QuidelOrtho (QDEL) Stock Is Nosediving
What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 21.3% in the afternoon session after the company slashed its full-year...
Via StockStory · August 7, 2026
Which stocks are gapping on Friday?chartmill.com
Via Chartmill · August 7, 2026
Top movers in Friday's pre-market sessionchartmill.com
Via Chartmill · August 7, 2026
QuidelOrtho Q2 Earnings Call Highlightsmarketbeat.com
QuidelOrtho (NASDAQ:QDEL) reported second-quarter revenue growth despite continued pressure from China and a softer respiratory testing environment, while lowering its full-year outlook and withdrawing free cash flow guidance.
Total second-quarter revenue was $631 million, up 2% on a constant-curre
Via MarketBeat · August 7, 2026
QDEL Q2 Deep Dive: Guidance Reset Amid China Headwinds and Respiratory Uncertainty
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 2.8% year on y...
Via StockStory · August 7, 2026